Characterization of antibody specificities associated with preeclampsia

Hypertension

Volumn 63, Issue 5, 2014, Pages 1086-1093

  Elliott, Serra E ^a   Parchim, Nicholas F ^b   Liu, Chen ^b   Xia, Yang ^b   Kellems, Rodney E ^b   Soffici, Alex R ^c   Daugherty, Patrick S ^a  

^a University of California   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c Department of Pharmacy Services   (United States)

Author keywords

Antibodies; Biological markers; Diagnosis; Peptide library; Preeclampsia

Indexed keywords

ANGIOTENSIN II; ANTIBODY; EPITOPE; PEPTIDE;

ADULT; ALGORITHM; ANTIBODY SPECIFICITY; ARTICLE; CELL SURFACE; CONTROLLED STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; MAJOR CLINICAL STUDY; PEPTIDE LIBRARY; PREECLAMPSIA; PRIORITY JOURNAL; SCREENING TEST; SEQUENCE ANALYSIS;

ANTIBODIES; BIOLOGICAL MARKERS; DIAGNOSIS; PEPTIDE LIBRARY; PREECLAMPSIA;

ADULT; ALGORITHMS; ANTIBODIES; ANTIBODY SPECIFICITY; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; EPITOPES; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 84902261852     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.02362     Document Type: Article

References (36)

1. Lain KY, Roberts JM Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA. 2002; 287: 3183-3186. (Pubitemid 34686089)
2. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005; 365: 785-799. (Pubitemid 40311367)
3. Sibai BM. Biomarker for hypertension-preeclampsia: are we close yet? Am J Obstet Gynecol. 2007; 197: 1-2. (Pubitemid 47001867)
4. Levine RJ, Maynard SE, Qian C, Lim K.H., England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs B.P., Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of pre-eclampsia. N Engl J Med. 2004; 350: 672-683. (Pubitemid 38364626)
5. Venkatesha S, Toporsian M, Lam C., et al Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006; 12: 642-649. (Pubitemid 43865232)
6. Cowans NJ, Stamatopoulou A, Khalil A., Spencer K. PP13 as a marker of pre-eclampsia: a two platform comparison study. Placenta. 2011; 32 (suppl):S37-S41.
7. Wallukat G, Homuth V, Fischer T., Lindschau C, Horstkamp B, Jüpner A, Baur E., Nissen E, Vetter K, Neichel D, Dudenhausen JW, Haller H, Luft FC. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest. 1999; 103: 945-952. (Pubitemid 29169601)
8. Benton SJ, Hu Y, Xie F., Kupfer K, Lee SW, Magee L.A., von Dadelszen P. Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays. Am J Obstet Gynecol. 2011; 205: 469.e1-469.e8.
9. Rana S, Powe CE, Salahuddin S, Verlohren S., Perschel FH, Levine RJ, Lim KH, Wenger J.B., Thadhani R., Karumanchi SA. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation. 2012; 125: 911-919.
10. Schneuer FJ, Nassar N, Guilbert C., Tasevski V, Ashton AW, Morris J.M., Roberts CL. First trimester screening of serum soluble fms-like tyrosine kinase-1 and placental growth factor predicting hypertensive disorders of pregnancy. Preg Hyper: An Int J Women's Card Health. 2013; 3: 215-221.
11. Walther T, Wallukat G, Jank A., Bartel S, Schultheiss H P, Faber R, Stepan H. Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature. Hypertension. 2005; 46: 1275-1279. (Pubitemid 43189723)
12. Zhou CC, Zhang Y, Irani R.A., Zhang H., Mi T, Popek EJ, Hicks M.J., Ramin SM, Kellems RE, Xia Y. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat Med. 2008; 14: 855-862.
13. Irani RA, Zhang Y, Blackwell S.C., Zhou CC, Ramin SM, Kellems RE, Xia Y. The detrimental role of angiotensin receptor agonistic autoantibod-ies in intrauterine growth restriction seen in preeclampsia. J Exp Med. 2009; 206: 2809-2822.
14. LaMarca B, Wallukat G, Llinas M., Herse F, Dechend R, Granger JP Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats. Hypertension. 2008; 52: 1168-1172.
15. Wang W, Irani RA, Zhang Y, Ramin S.M., Blackwell SC, Tao L, Kellems RE, Xia Y. Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia. Hypertension. 2012; 60: 712-721.
16. Salmon JE, Heuser C, Triebwasser M., Liszewski MK, Kavanagh D, Roumenina L, Branch D.W., Goodship T., Fremeaux-Bacchi V, Atkinson JP. Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort. PLoS Med. 2011; 8:e1001013.
17. Hering L, Herse F, Verlohren S., Park JK, Wellner M, Qadri F, Pijnenborg R., Staff AC, Huppertz B, Muller DN, Luft FC, Dechend R. Trophoblasts reduce the vascular smooth muscle cell proatherogenic response. Hypertension. 2008; 51: 554-559. (Pubitemid 351156447)
18. Jensen F, Wallukat G, Herse F., Budner O, El-Mousleh T, Costa SD, Dechend R, Zenclussen AC CD19+CD5+ cells as indicators of pre-eclampsia. Hypertension. 2012; 59: 861-868.
19. Darmochwal-Kolarz D., Saito S, Tabarkiewicz J., Kolarz B, Rolinski J, Leszczynska-Gorzelak B, Oleszczuk J. Apoptosis signaling is altered in CD4(+)CD25(+)FoxP3(+) T regulatory lymphocytes in pre-eclampsia. Int J Mol Sci. 2012; 13: 6548-6560.
20. Sakaguchi S, Sakaguchi N, Shimizu J., Yamazaki S, Sakihama T, Itoh M., Kuniyasu Y, Nomura T, Toda M, Takahashi T. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev. 2001; 182: 18-32. (Pubitemid 33070205)
21. Siddiqui AH, Irani RA, Blackwell S.C., Ramin SM, Kellems RE, Xia Y. Angiotensin receptor agonistic autoantibody is highly prevalent in preeclamp-sia: correlation with disease severity. Hypertension. 2010; 55: 386-393.
22. Herse F, Verlohren S, Wenzel K., Pape J, Muller DN, Modrow S, Wallukat G., Luft FC, Redman CW, Dechend R. Prevalence of agonistic autoanti-bodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study. Hypertension. 2009; 53: 393-398.
23. Liao YH, Wei YM, Wang M, Wang Z.H., Yuan HT, Cheng LX Autoantibodies against AT1-receptor and alpha1-adrenergic receptor in patients with hypertension. Hypertens Res. 2002; 25: 641-646.
24. Dragun D, Müller DN, Bräsen JH, et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med. 2005; 352: 558-569. (Pubitemid 40204669)
25. Hall SS, Daugherty PS Quantitative specificity-based display library screening identifies determinants of antibody-epitope binding specificity. Protein Sci. 2009; 18: 1926-1934.
26. Casadaban MJ, Cohen SN Analysis of gene control signals by DNA fusion and cloning in Escherichia coli. J Mol Biol. 1980; 138: 179-207. (Pubitemid 10044378)
27. Rice JJ, Daugherty PS Directed evolution of a biterminal bacterial display scaffold enhances the display of diverse peptides. Protein Eng Des Sel. 2008; 21: 435-442. (Pubitemid 351882133)
28. Kenrick SA, Daugherty PS Bacterial display enables efficient and quantitative peptide affinity maturation. Protein Eng Des Sel. 2010; 23: 9-17.
29. Friedman J, Hastie T, Tibshirani R. Additive logistic regression: a statistical view of boosting. Ann Stat. 2000; 28: 337-407. (Pubitemid 33227445)
30. Culp M, Johnson K, Michailidis G. ada: an R package for stochastic boosting. J Stat Softw. 2006; 17: 1-27. (Pubitemid 44643721)
31. Ma G, Li Y, Zhang J., Liu H, Hou D, Zhu L., Zhang Z, Zhang L. Association between the presence of autoantibodies against adreno-receptors and severe pre-eclampsia: a pilot study. PLoS One. 2013; 8: e57983.
32. do Prado A.D., Piovesan DM, Staub H.L., Horta BL Association of anticardio-lipin antibodies with preeclampsia: a systematic review and meta-analysis. Obstet Gynecol. 2010; 116: 1433-1443.
33. Marozio L, Curti A, Botta G., Canuto EM, Salton L, Tavella AM, Benedetto C. Anti-prothrombin antibodies are associated with adverse pregnancy outcome. Am J Reprod Immunol. 2011; 66: 404-409.
34. Rossitto G, Regolisti G, Rossi E., Negro A, Nicoli D, Casali B., Toniato A, Caroccia B, Seccia TM, Walther T, Rossi GP. Elevation of angiotensin-II type-1-receptor autoantibodies titer in primary aldosteronism as a result of aldosterone-producing adenoma. Hypertension. 2013; 61: 526-533.
35. Rabel PO, Planitzer CB, Farcet M.R., Kreil TR Tick-borne encephalitis virus-neutralizing antibodies in different immunoglobulin preparations. Clin Vaccine Immunol. 2012; 19: 623-625.
36. Chaiworapongsa T, Romero R, Korzeniewski S.J., Kusanovic JP, Soto E, Lam J, Dong Z., Than NG, Yeo L, Hernandez-Andrade E, Conde-Agudelo A, Hassan SS. Maternal plasma concentrations of angiogenic/antiangio-genic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia. Am J Obstet Gynecol. 2013; 208: 287.e1-287.e15.